- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00729014
A Study of Drug-Induced Kidney Disease
August 1, 2008 updated by: National Taiwan University Hospital
The purpose of this study is to identify incidence of Chinese herb nephropathy in a medical center
Study Overview
Status
Unknown
Conditions
Detailed Description
This is a retrospective study, by computer screening, chart review and phone survey to find herbal nephropathy and determine the cause-relationship.
Using ICD-9-CM code as a tool to screen the newly diagnosed ESRD in NTUH computer data base, and divided patients into those with underlying disease(s) that cause the renal failure and those without.
Study Type
Observational
Enrollment (Anticipated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Fe-Lin L Wu, MSCP, Ph.D
- Phone Number: 8389 886-2-23123456
- Email: flwu@ntu.edu.tw
Study Contact Backup
- Name: Kwan-Dun Wu, MD, Ph.D
- Phone Number: 5014 886-2-23123456
- Email: kdwu@ntuh.gov.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- National Taiwan University Hospital
-
Contact:
- Fe-Lin L. Wu, MSCP,Ph D
- Phone Number: 8389 +886-2-23123456
- Email: flwu@ntu.edu.tw
-
Contact:
- Kwan-Dun Wu, MD, PhD
- Phone Number: 5014 +886-2-23123456
- Email: kdwu@ntuh.gov.tw
-
Principal Investigator:
- Fe-Lin L. Wu, Ph D
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
a medical center
Description
Inclusion Criteria:
- patient who was newly diagnosed as end stage renal disease who need dialysis
Exclusion Criteria:
- started dialysis before 2000
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The incidence of herbal nephropathy
Time Frame: 5 years
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The epidemiology of primary diagnosis for end stage renal disease in Taiwan
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kwan-Dun Wu, MD, PhD, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Anticipated)
September 1, 2008
Study Registration Dates
First Submitted
August 1, 2008
First Submitted That Met QC Criteria
August 1, 2008
First Posted (Estimate)
August 6, 2008
Study Record Updates
Last Update Posted (Estimate)
August 6, 2008
Last Update Submitted That Met QC Criteria
August 1, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 200804062R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Renal Disease
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
University of Illinois at ChicagoWithdrawnObesity | End-Stage Renal Disease | Renal Disease, End-Stage | Renal Failure, End-StageUnited States
-
Bioconnect Systems, IncCompletedEnd-stage Renal Disease | End-stage Kidney DiseaseUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...Changhai Hospital; Shanghai Zhongshan Hospital; RenJi Hospital; Ruijin Hospital; Shanghai... and other collaboratorsCompleted
-
Clinical Research Center for End Stage Renal Disease...Kyungpook National University Hospital; Medical Research Collaborating Center... and other collaboratorsActive, not recruitingEnd-Stage Renal DiseaseKorea, Republic of
-
Medtronic - MITGCompletedEnd-stage Renal DiseaseGermany
-
China Medical University HospitalUnknown
-
Guangdong Provincial Hospital of Traditional Chinese...Ministry of Science and Technology of the People´s Republic of ChinaUnknown
-
University of California, San FranciscoCompletedEnd-stage Renal DiseaseUnited States
-
Mark A. LumleyHenry Ford Health SystemCompleted